It is confirmed that group of industry owners acquired CorePharma, LLC from Impax. More sale is coming ahead. Further more in the state of the union 2018, Trump mentioned about reducing prices of prescription drug. This will create more pressure for amneal and impax to compete and be profitable in the market. This will be followed by some layoffs, which are inevitable for combined company to survive in the market.
There are no replies in this thread yet. Be the first to post a reply below: